Objective: Despite technical advances in peritoneal dialysis (PD), mortality rates are still very high. Factors affecting mortality have been the aim of many studies. However, there are not enough studies investigating the effects of socio-economic status (SES) and medical treatments on mortality. The aim of our study is to investigate the long-term effects of SES and medical treatments on mortality in PD patients. Material and Methods: The study included 145 patients. Demographic characteristics, laboratory data, and medical treatments were recorded. Three main variables play a role in the SES indices. These variables are education, income level and occupation. These variables were questioned in PD patients. Cox regression analysis was used to determine the factors affecting mortality. Results: The mean age of the patients was 57.51±15.73 years, and 14% had a low income level. After 3.8±3.6 years of follow-up, 27.6% of the patients had died. The income level was lower, the tendency to infection was higher in the non-survivor group. There was no difference between survivor and non-survivor group in terms of gender, age, marital status, PD duration. Factors affecting mortality were low income [hazard ratio (HR): 2.272, 95% confidence interval (CI): 1.12-4.812, p=0.001], using high peritoneal dialysate glucose concentration solution, and low use of phosphorusbinding drugs and calcitriol (HR: 2.812, 95% CI: 1.160-6.818 and HR: 3.632, 95% CI: 1.665-7.291, p=0.001, respectively). Conclusion: Low income level in PD patients increases mortality by creating a tendency to infections. Lack of volume control and malnutrition are other factors affecting mortality.
Keywords: Hypervolemia; malnutrition; mortality; peritoneal dialysis; socio-economic status
Amaç: Periton diyalizinde teknik gelişmelere rağmen mortalite oranları hâlâ yüksektir. Mortaliteyi etkileyen faktörler birçok çalışmanın amacı olmuştur. Ancak sosyoekonomik düzeylerin (SED) ve tıbbi tedavinin mortalite üzerine etkisi ile ilgili yeteri kadar araştırma yapılmamıştır. Bu çalışmanın amacı, SED ve tıbbi tedavinin uzun dönemde periton diyaliz hastalarında mortalite üzerine etkisini araştırmaktır. Gereç ve Yöntemler: Çalışmaya 145 hasta alındı. Demografik özellikler, tıbbi tedaviler ve laboratuvar verileri kaydedildi. SED endekslerinde 3 ana değişken rol oynamaktadır. Bu değişkenler eğitim, gelir düzeyi ve meslektir. Bu değişkenler, periton diyaliz hastalarında tek tek sorgulandı. Mortaliteyi etkileyen faktörlerin tespiti için Cox regresyon analizinden yararlanıldı. Bulgular: Hastaların yaş ortalaması 57,51±15,73 yıl olup, %14'ü düşük gelir düzeyine sahipti. Hastaların %27,6'sı 3,8±3,6 yıllık takip sonrası öldü. Yaşamayan hasta grubunda gelir düzeyi daha düşük ve enfeksiyona eğilim daha fazlaydı. Yaşayan ve yaşamayan hasta gruplar arasında yaş, cinsiyet, medeni durum ve periton diyaliz süresi açısından anlamlı bir fark yoktu. Mortaliteyi etkileyen faktörler ise düşük gelir düzeyi 'tehlike oranı [hazard ratio (HR)]: 2,272, %95 güven aralığı [confidence interval (CI)]: 1,12-4,812, p=0,001', yüksek glukoz konsantrasyonlu periton diyaliz solüsyonu kullanma, fosfor bağlayıcı ajan ve kalsitriol kullanımının az olmasıydı (sırasıyla HR: 2,812, %95 CI: 1,160-6,818 ve HR: 3,632, %95 CI: 1,665-7,291, p=0,001). Sonuç: Periton diyaliz hastalarında düşük gelir düzeyine sahip olmak, enfeksiyona eğilim yaratarak mortaliteyi etkilemektedir. Volüm durumunu yeteri kadar kontrol altına alamama ve malnütrisyon mortaliteyi etkileyen diğer faktörlerdir.
Anahtar Kelimeler: Hipervolemi; malnütrisyon; mortalite; periton diyalizi; sosyoekonomik düzey
- United States Renal Data System [Internet]. [Cited: 10 Agust 2022]. 2022 Annual Data Report. Available from: [Link]
- Song MK, Lin FC, Gilet CA, Arnold RM, Bridgman JC, Ward SE. Patient perspectives on informed decision-making surrounding dialysis initiation. Nephrol Dial Transplant. 2013;28(11):2815-23. [Crossref] [PubMed] [PMC]
- Grace BS, Clayton P, Cass A, McDonald SP. Socio-economic status and incidence of renal replacement therapy: a registry study of Australian patients. Nephrol Dial Transplant. 2012;27(11):4173-80. [Crossref] [PubMed]
- Grace BS, Clayton PA, Gray NA, McDonald SP. Socioeconomic differences in the uptake of home dialysis. Clin J Am Soc Nephrol. 2014;9(5):929-35. [Crossref] [PubMed] [PMC]
- Ward FL, O'Kelly P, Donohue F, O'Haiseadha C, Haase T, Pratschke J, et al. The influence of socioeconomic status on patient survival on chronic dialysis. Hemodial Int. 2015;19(4):601-8. [Crossref] [PubMed]
- Plantinga LC. Socio-economic impact in CKD. Nephrol Ther. 2013;9(1):1-7. [Crossref] [PubMed]
- Vart P, Gansevoort RT, Joosten MM, Bültmann U, Reijneveld SA. Socioeconomic disparities in chronic kidney disease: a systematic review and meta-analysis. Am J Prev Med. 2015;48(5):580-92. [Crossref] [PubMed]
- Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, et al. Socioeconomic status in health research: one size does not fit all. JAMA. 2005;294(22):2879-88. [Crossref] [PubMed]
- Shavers VL. Measurement of socioeconomic status in health disparities research. J Natl Med Assoc. 2007;99(9):1013-23. [PubMed] [PMC]
- Tao S, Zeng X, Liu J, Fu P. Socioeconomic status and mortality among dialysis patients: a systematic review and meta-analysis. Int Urol Nephrol. 2019;51(3):509-18. [Crossref] [PubMed]
- Sandhu GS, Khattak M, Rout P, Williams ME, Gautam S, Baird B, et al. Social Adaptability Index: application and outcomes in a dialysis population. Nephrol Dial Transplant. 2011;26(8):2667-74. [Crossref] [PubMed]
- Porche DJ. Poverty and Men's Health. Am J Mens Health. 2007;1(4):241. [Crossref] [PubMed]
- Ahrenfeldt LJ, Pedersen JK, Thinggaard M, Christensen K, Lindahl-Jacobsen R. Sex differences in health and mortality by income and income changes. J Epidemiol Community Health. 2020;74(3):225-31. [Crossref] [PubMed] [PMC]
- Chen X, Mao G, Leng SX. Frailty syndrome: an overview. Clin Interv Aging. 2014;9:433-41. [Crossref] [PubMed] [PMC]
- Nitta K, Hanafusa N, Tsuchiya K. Role of frailty on outcomes of dialysis patients. Contrib Nephrol. 2018;195:102-9. [Crossref] [PubMed]
- Sy J, McCulloch CE, Johansen KL. Depressive symptoms, frailty, and mortality among dialysis patients. Hemodial Int. 2019;23(2):239-46. [Crossref] [PubMed] [PMC]
- Kamijo Y, Kanda E, Ishibashi Y, Yoshida M. Sarcopenia and frailty in PD: impact on mortality, malnutrition, and inflammation. Perit Dial Int. 2018;38(6):447-54. [Crossref] [PubMed]
- Zhang Q, Ma Y, Lin F, Zhao J, Xiong J. Frailty and mortality among patients with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. 2020;52(2):363-70. [Crossref] [PubMed]
- Holmes C, Mujais S. Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int Suppl. 2006;(103):S104-9. [Crossref] [PubMed]
- Liu J, Rosner MH. Lipid abnormalities associated with end-stage renal disease. Semin Dial. 2006;19(1):32-40. [Crossref] [PubMed]
- Rasić S, Hadzović-Dzuvo A, Rebić D, Uncanin S, Hadzić A, Mujaković A, et al. The metabolic syndrome in patients on peritoneal dialysis: prevalence and influence on cardiovascular morbidity. Bosn J Basic Med Sci. 2010;10 Suppl 1(Suppl 1):S3-7. [Crossref] [PubMed] [PMC]
- Hyun SH, Choi JY, Cho JH, Park SH, Kim CD, Kim YL. Assessment of fluid and nutritional status using multifrequency bioelectrical impedance analysis in peritoneal dialysis patients. Blood Purif. 2014;37(2):152-62. [Crossref] [PubMed]
- Kim YL, Biesen WV. Fluid Overload in Peritoneal Dialysis Patients. Semin Nephrol. 2017;37(1):43-53. [Crossref] [PubMed]
- Paniagua R, Ventura MD, Avila-Díaz M, Hinojosa-Heredia H, Méndez-Durán A, Cueto-Manzano A, et al. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant. 2010;25(2):551-7. [Crossref] [PubMed]
- Hogas S, Ardeleanu S, Segall L, Serban DN, Serban IL, Hogas M, et al. Changes in arterial stiffness following dialysis in relation to overhydration and to endothelial function. Int Urol Nephrol. 2012;44(3):897-905. [Crossref] [PubMed]
- Guo Q, Lin J, Li J, Yi C, Mao H, Yang X, et al. The effect of fluid overload on clinical outcome in southern Chinese patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int. 2015;35(7):691-702. [Crossref] [PubMed] [PMC]
- Demirci MS, Demirci C, Ozdogan O, Kircelli F, Akcicek F, Basci A, et al. Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patients. Nephrol Dial Transplant. 2011;26(5):1708-16. [Crossref] [PubMed]
- Cheng LT, Tang W, Wang T. Strong association between volume status and nutritional status in peritoneal dialysis patients. Am J Kidney Dis. 2005;45(5):891-902. [Crossref] [PubMed]
- Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ, et al. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant. 2003;18(4):797-803. [Crossref] [PubMed]
- Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003;42(5):864-81. [Crossref] [PubMed]
- Haarhaus M, Evenepoel P; European Renal Osteodystrophy (EUROD) workgroup; Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA). Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment. Kidney Int. 2021;100(3):546-58. [Crossref] [PubMed]
- Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208-18. [Crossref] [PubMed]
- Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M, et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant. 2004;19(6):1480-8. [Crossref] [PubMed]
- Naves-Díaz M, Passlick-Deetjen J, Guinsburg A, Marelli C, Fernández-Martín JL, Rodríguez-Puyol D, et al. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. Nephrol Dial Transplant. 2011;26(6):1938-47. [Crossref] [PubMed]
- Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, et al; ARO Investigators. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011;26(6):1948-55. [Crossref] [PubMed] [PMC]
.: Process List